Table 1.
Variable | Mean (SD) | N (%) | H/O KFDV Vaccination | ||
---|---|---|---|---|---|
No (n = 22) | Yes (n = 22) | P value | |||
Mean age in year | 40.93 (13.1) | ||||
Gender | |||||
Male | 18 (40.9) | 11 | 7 | 0.3454 | |
Female | 26 (59.1) | 11 | 15 | 0.4328 | |
Hospitals | |||||
CHC Valpoi, Goa | 23 (52.3) | 15 | 8 | 0.1444 | |
JCH Thirthahalli, Karnataka | 13 (29.5) | 2 | 11 | 0.0125 | |
RH Dodamarg, SDH Sawanthwad, PHC Banda Maharashtra | 8 (18.2) | 5 | 3 | 0.4795 | |
Socio economic status# | |||||
Low < 40 | 27 (61.3) | 14 | 13 | 0.8474 | |
Middle 40–70 | 17 (38.7) | 8 | 9 | 0.8084 | |
Clinical status (n = 44) | |||||
Fever | 44 (100) | 22 | 22 | 1.0 | |
Myalgia | 39 (88.6) | 18 | 22 | 0.108 | |
General weakness | 37 (84.1) | 19 | 19 | 1.0 | |
Headache | 37 (84.1) | 20 | 18 | 0.664 | |
Nausea | 26 (59.1) | 12 | 15 | 0.537 | |
Cough | 20 (45.5) | 9 | 12 | 0.547 | |
Vomiting | 14 (31.2) | 10 | 5 | 0.203 | |
Diarrhoea | 12 (27.3) | 7 | 5 | 0.736 | |
Altered sensorium and/or seizure | 3 (6.8) | 3 | 0 | 0.233 | |
Hemorrhagic signs | 1 (2.3) | 1 | 0 | 1.0 | |
Hypotension | 18 (40.9) | 9 | 11 | 0.763 | |
Deceased | 2 (4.5) | 2 | 0 | 0.488 | |
Laboratory features | |||||
Mean total leukocyte count/mm3 (n = 41) | 2,588 (1627) | 2,339 | 2,825 | 0.345 | |
Mean platelet count × 103/µl (n = 39) | 124 (50) | 104 | 139 | 0.031* | |
Aspartate aminotransferase IU/L (n = 25) | 208.7 (338) | 326 | 80 | 0.681 | |
Alanine aminotransferase IU/L (n = 25) | 102.6 (136) | 147 | 54.6 | 0.907 | |
Alkaline phosphatase IU/L (n = 23) | 211 (92.9) | 222.3 | 196.8 | 0.525 | |
C-Reactive protein < 10 mg/dl (N = 24) | 2.6 (2.2) | 2.49 | 2.8 | 0.733 | |
Mean duration hospitalization (days) (n = 43) | 5.2 (2.7) | 5.04 | 5.4 | 0.653 | |
H/O of KFD vaccination | |||||
Unvaccinated | 22 (50) | ||||
Vaccinated at least one dose | 22 (50) | ||||
Vaccinated two/three dose | 16 (36.4) |
*Significant difference, #modified Udai Pareekh scale.